1. Introduction {#sec1-ijms-16-26135}
===============

Glaucoma is a chronic and progressive group of optic neuropathies affecting more than 60 million people globally \[[@B1-ijms-16-26135]\]. It is associated with death of retinal ganglion cells resulting in characteristic cupping or degeneration of the optic nerve head and loss of peripheral vision \[[@B2-ijms-16-26135]\]. Primary open angle glaucoma (POAG) is one of the most common types of glaucoma which is clinically characterized by an open and normal anterior iridocorneal chamber angle \[[@B2-ijms-16-26135]\]. POAG can either occur with increased intraocular pressure (IOP) or normal IOP, the latter being referred to as normal-tension glaucoma (NTG).

Although there are many postulated mechanisms of retinal ganglion cell damage, the exact etiology of POAG still remains obscure. The well-recognized risk factors associated with POAG include elevated IOP, age, family history, gender, ethnicity, central corneal thickness, and myopia. A recent large prospective study indicated that POAG with early paracentral visual field loss displays distinct as well common risk factor profiles as compared to those with peripheral vision loss \[[@B3-ijms-16-26135]\]. Raised IOP is the most important and the only modifiable risk factor in the development and progression of POAG. Several large population-based studies in the past have confirmed that the reduction of IOP reduces the progression of glaucoma in patients with or without elevated IOP \[[@B4-ijms-16-26135],[@B5-ijms-16-26135],[@B6-ijms-16-26135],[@B7-ijms-16-26135],[@B8-ijms-16-26135]\].

Similarly, findings of the meta-analysis from the Eye Diseases Prevalence Research Group have shown that the occurrence of glaucoma increases with increasing age among all ethnicities (Europeans, Blacks, and Hispanics) \[[@B7-ijms-16-26135],[@B9-ijms-16-26135]\]. Age was also reported to be associated with POAG in patients with ocular hypertension in two large population-based studies \[[@B5-ijms-16-26135],[@B8-ijms-16-26135]\]. Family history is another important risk factor in the development of glaucoma \[[@B7-ijms-16-26135],[@B10-ijms-16-26135],[@B11-ijms-16-26135],[@B12-ijms-16-26135]\]. A positive family history of POAG significantly increases the odds (varying from five to 10 times) for the development of POAG \[[@B13-ijms-16-26135]\]. In the Melbourne \[[@B14-ijms-16-26135]\] and Rotterdam studies \[[@B11-ijms-16-26135]\], males showed a trend towards increased risk of POAG which was absent in the Barbados Eye Study \[[@B7-ijms-16-26135]\] and the Beaver Dam Eye Study \[[@B10-ijms-16-26135]\]. Similarly, the Eye Disease Prevalence Research Group \[[@B9-ijms-16-26135]\] reported no gender-related association of glaucoma among the European, African American, and Hispanic subjects. However, a recent systematic review of 3497 POAG cases out of 146,882 participants with gender-specific data showed that the age-adjusted prevalence is higher in men compared to women, and that this finding remains consistent across all ethnic groups provides very strong evidence for the association of POAG with gender \[[@B15-ijms-16-26135]\]. Several studies have shown POAG to be more prevalent with rapid and severe disease progression in people of African-Caribbean as compared to European descent, Hispanics, and Asians \[[@B9-ijms-16-26135],[@B16-ijms-16-26135]\]. Central corneal thickness (CCT) has also been reported to be associated with POAG, particularly in the ocular hypertension patients \[[@B17-ijms-16-26135],[@B18-ijms-16-26135]\]. Although the precise mechanism(s) are still unclear, this may be in part due to the effect of corneal thickness on IOP measurement, and increased susceptibility to optic nerve damage \[[@B19-ijms-16-26135],[@B20-ijms-16-26135]\]. In addition, studies have shown that individuals with thicker corneas are less responsive to topical ocular hypotensive medications \[[@B21-ijms-16-26135]\]. Myopia is also considered to be an important risk factor for POAG as it can increase susceptibility of myopic nerves to glaucomatous damage \[[@B22-ijms-16-26135]\]. Moderate-to-high levels of myopia conferred two- to three-fold increased risk in the Australian \[[@B23-ijms-16-26135]\], US Caucasian \[[@B24-ijms-16-26135]\], and the Chinese populations \[[@B25-ijms-16-26135]\]. Other predisposing factors for POAG include adult-onset diabetes and hypertension. Although there are conflicting reports regarding the risk of POAG in individuals with diabetes \[[@B26-ijms-16-26135],[@B27-ijms-16-26135]\], a recent systematic review and meta-analysis of 13 studies, which included six population-based cohorts and seven case-control studies, showed increased risk of POAG (relative risk of 1.4 and 1.49, respectively) in individuals with diabetes \[[@B28-ijms-16-26135]\]. Multiple epidemiological studies have also reported a role of hypertension as a risk factor for POAG \[[@B23-ijms-16-26135],[@B29-ijms-16-26135]\]. Treatment of hypertensive patients with beta-blockers results in nocturnal hypotension and is a potential risk factor for glaucomatous optic neuropathy \[[@B30-ijms-16-26135]\]. The mechanism(s) by which hypertension induces optic nerve damage are still unclear.

POAG is a genetically complex trait with a substantial fraction exhibiting a significant heritability. Genetic linkage studies of large affected families have so far identified at least 20 chromosomal loci (GLC1A-P) that are linked to POAG. The causative genes that are capable of causing POAG with minimal influence from other gene(s) or the environment and that have been consistently implicated so far include myocilin (*MYOC*), optineurin (*OPTN*), WD repeat domain 36 (*WDR36*), ankyrin repeat and SOCS-box containing 10 (*ASB10*), Cytochrome P450 family 1, subtype B, polypeptide 1 (*CYP1B1*), and neurotrophin 4 (*NTF4*) as reviewed elsewhere \[[@B31-ijms-16-26135],[@B32-ijms-16-26135]\]. Twin studies and family-based studies have discovered a number of genes. However, these disease-causing genes account for \<10% of POAG cases in the general population. It is therefore likely that the hereditary aspect of many of the remaining cases of POAG is due to the combined effects of several genes (polygenic) and that gene-environment interactions are important. Quantitative endophenotype traits related to POAG pathogenesis such as IOP, vertical cup-to-disc ratio (VCDR), and CCT \[[@B10-ijms-16-26135],[@B33-ijms-16-26135],[@B34-ijms-16-26135]\] are highly heritable, likely to be influenced at least in part by genes, and are highly polymorphic. Recent advances in genomic technologies and genome-wide association studies (GWAS) have greatly accelerated the discovery and understanding of genes and genomic regions associated with POAG and influencing the quantitative endophenotype traits related to POAG pathogenesis, which will be the main focus of this chapter.

2. Epidemiology of POAG {#sec2-ijms-16-26135}
=======================

Recent epidemiological studies suggest that, in 2013, almost 64.3 million people (aged between 40 and 80 years) were affected by glaucoma globally, and this number is expected to increase to 76.0 million by 2020 and to 111.8 million by 2040 due to the population aging \[[@B35-ijms-16-26135]\]. POAG accounts for a major three-quarters (74%) of all glaucoma cases \[[@B1-ijms-16-26135]\]. Another recent meta-analysis estimated the global number of POAG cases in 2015 at 57.5 million, rising to 65.5 million by 2020 \[[@B15-ijms-16-26135]\]. Almost half (47%) of these will those of Asian descent, while a quarter (24%) will be European \[[@B1-ijms-16-26135]\]. The risk and subtypes of glaucoma are known to vary among races and countries \[[@B36-ijms-16-26135]\]. A meta-analysis conducted by the Eye Disease Prevalence Research Group showed that, in the United States, African Americans have a higher POAG prevalence than Caucasians. The prevalence of POAG in individuals ≥40 years old was observed to be 1.86%, including 1.57 million Caucasian and 398,000 African American subjects. In 2020, this number is estimated to rise up to 3.36 million due to the population aging \[[@B9-ijms-16-26135]\]. In all the age groups, there was an increased prevalence of glaucoma in individuals of African descent compared with European-derived individuals \[[@B37-ijms-16-26135]\]. Similarly, a recent meta-analysis of 81 studies including 37 countries, 216,214 participants, and 5266 POAG cases reported that the Black populations had the highest POAG prevalence of 5.2% (95% credible interval (CrI) 3.7%, 7.2%) at 60 years, rising to 12.2% (95% CrI 8.9% to 16.6%) at 80 years. The increase in POAG prevalence per decade of age was found to be highest among the Hispanics (2.31, 95% CrI 2.12, 2.52) and Caucasian populations (1.99, 95% CrI 1.86, 2.12), and lowest in East and South Asians (1.48, 95% CrI 1.39, 1.57; 1.56, 95% CrI 1.31, 1.88, respectively). In addition, men were more likely to have POAG than women (1.30, 95% CrI 1.22, 1.41). It is clearly evident that individuals of African descent are associated with increased risk (estimated incidence is two to five times higher) of developing glaucoma compared with individuals of European descent. The reasons for this increased risk of glaucoma among individuals of African descent are still not clear. The Barbados Eye Study reported a prevalence of 7% in Africans, suggesting an influence of ancestral factors \[[@B7-ijms-16-26135]\]. Several other factors that may also be influential could be physiological or anatomical differences in the optic disc or corneas, environmental factors, social differences or genetics \[[@B26-ijms-16-26135]\].

3. Genotype-Phenotype Association in POAG {#sec3-ijms-16-26135}
=========================================

Association studies using the candidate-gene approach and GWASs have been particularly useful tools in identifying genetic factors, each of which may have a relatively small effect but contributes to a large number of cases. Unlike the candidate-gene approach, GWAS is an unbiased (without bias to known protein functionality gene) genome-wide approach that compares the genotypic profile of single nucleotide polymorphisms (SNPs) throughout the genome in cases (affected) and controls (unaffected), thus identifying genomic region(s) associated with a disease or trait of interest. The large population sample required in GWASs to achieve a genome-wide statistical significance (*p*-value of less than 5 × 10^−8^) has been greatly facilitated by the formation of the International Consortia. However, since GWAS can rarely identify functional or causal variant(s), further in-depth genotyping and functional testing in addition to replication studies in independent cohorts of different population groups are considered a standard requirement to conclusively validate genes or genomic regions identified from GWAS. Using this powerful approach (GWAS), recent genetic studies have identified genes or genetic variants with modest effect to be associated with POAG and related quantitative traits ([Table 1](#ijms-16-26135-t001){ref-type="table"}). These studies have provided better insights into the genetic basis of POAG and improved our understanding of the underlying pathophysiology of the disease.

ijms-16-26135-t001_Table 1

###### 

Genes and polymorphisms identified in POAG using genome-wide and candidate-gene approaches in the Middle East and other populations.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Studies                                                                        Gene/Chromosome                       SNP ID                                                                               Population \*                                                      Study Type                                                                                      Study Size (POAG/Controls) \*                                   OR/Beta, *p* Value                                                                                Any Clinical Association \*
  ------------------------------------------------------------------------------ ------------------------------------- ------------------------------------------------------------------------------------ ------------------------------------------------------------------ ----------------------------------------------------------------------------------------------- --------------------------------------------------------------- ------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------
  **GWAS Studies**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Nakano *et al.*, 2009 \[[@B38-ijms-16-26135]\]                                 *PLXDC2 (10p12.31)*                   rs7081455                                                                            D: Japan\                                                          GWAS                                                                                            D: 1519\                                                        OR = 1.49, *p* = 1 × 10^−5^                                                                       --
                                                                                                                                                                                                            R: Japan                                                                                                                                                           R: 857                                                                                                                                                            

  *TMTC2 (12q21.31)*                                                             rs7961953                             OR = 1.37, *p* = 7 × 10^−5^                                                          --                                                                                                                                                                                                                                                                                                                                   

  *ZP4 (1q43)*                                                                   rs547984                              OR = 1.34, *p* = 6 × 10^−5^                                                          --                                                                                                                                                                                                                                                                                                                                   

  rs540782                                                                       OR =1.34, *p* = 6 × 10^−5^                                                                                                                                                                                                                                                                                                                                                                                                                                      

  rs693421                                                                       OR = 1.35, *p* = 4 × 10^−5^                                                                                                                                                                                                                                                                                                                                                                                                                                     

  rs2499601                                                                      OR = 1.33, *p* = 9 × 10^−5^                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Meguro *et al.*, 2010 \[[@B39-ijms-16-26135]\]                                 *SRBD1 (2p21)*                        rs3213787                                                                            Japanese                                                           GWAS                                                                                            D: 305\                                                         OR = 2.80, *p* = 2.5 × 10^−9^                                                                     Associated with NPG
                                                                                                                                                                                                                                                                                                                                                                               R: 355                                                                                                                                                            

  *ELOVL5 (6p12.1)*                                                              rs735860                              --                                                                                   --                                                                 --                                                                                              OR = 1.69, *p* = 4.1 × 10^−6^                                   Associated with NPG                                                                               

  Thorleifsson *et al.*, 2010 \[[@B40-ijms-16-26135]\]                           *CAV1/CAV2 (7q31.1)*                  rs4236601                                                                            D: Iceland\                                                        GWAS                                                                                            D: 36,140\                                                      OR = 1.36, *p* = 5 × 10^−10^                                                                      Nominal association was observed for increased IOP (*p* = 0.034)
                                                                                                                                                                                                            R1: SW, UK, AU\                                                                                                                                                    R1: 4239\                                                                                                                                                         
                                                                                                                                                                                                            R2: China                                                                                                                                                          R2: 879                                                                                                                                                           

  rs1052990                                                                      OR = 1.32, *p* = 1.1 × 10^−9^         --                                                                                                                                                                                                                                                                                                                                                                                                                        

  Burdon *et al.*, 2011 \[[@B41-ijms-16-26135]\]                                 *CDKN2B-AS (9p21.3)*                  rs4977756                                                                            AU, NZ                                                             GWAS                                                                                            D: 590/3956\                                                    OR = 1.50, *p* = 4.7 × 10^−9^                                                                     --
                                                                                                                                                                                                                                                                                                                                                                               R: 4148                                                                                                                                                           

  *TMCO1 (1q24)*                                                                 rs4656461                             OR = 1.68, *p* = 6.1 × 10^−10^                                                       --                                                                                                                                                                                                                                                                                                                                   

  Wiggs *et al.*, 2012 \[[@B42-ijms-16-26135]\]                                  *CDKN2B-AS (9p21)*                    rs2157719                                                                            US Caucasian                                                       GWAS                                                                                            D: 3146/3487                                                    OR = 0.69, *p* = 1.86 × 10^−18^                                                                   Also associated with NPG. OR =  0.58, *p*  =  1.17 × 10^−12^

  *SIX1/SIX6 (14q23)*                                                            rs10483727                            OR = 1.32, *p* = 3.87 × 10^−11^                                                      --                                                                                                                                                                                                                                                                                                                                   

  *8q22*                                                                         rs284489                              OR = 0.62, *p* = 8.88 × 10^−10^                                                      Associated with NPG                                                                                                                                                                                                                                                                                                                  

  Osman *et al.*, 2012 \[[@B43-ijms-16-26135]\]                                  *CDKN2B-AS (9p21)*                    rs1063192                                                                            Japanese                                                           GWAS                                                                                            D: 7993\                                                        OR = 0.75, *p* = 5.2 × 10^−11^                                                                    --
                                                                                                                                                                                                                                                                                                                                                                               R: 9014                                                                                                                                                           

  *SIX1/SIX6 (14q23)*                                                            rs10483727                            OR = 0.79, *p* = 9.49 × 10^−8^                                                       --                                                                                                                                                                                                                                                                                                                                   

  *NCKAP5* *(2q21.2)*                                                            rs7588567                             OR = 0.85, *p* = 3.89 × 10^−7^                                                       --                                                                                                                                                                                                                                                                                                                                   

  Nakano *et al.*, 2012 \[[@B44-ijms-16-26135]\]                                 *CDKN2B-AS (9p21.3)*                  rs7865618                                                                            Japanese                                                           GWAS                                                                                            D: 833/686\                                                     OR = 1.78, *p* = 9.0 × 10^−11^                                                                    Strongly associated with POAG and POAG/NPG, but not with HPG
                                                                                                                                                                                                                                                                                                                                                                               R: 411/289                                                                                                                                                        

  rs523096                                                                       OR = 1.76, *p* =1.6 × 10^−10^                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Takamoto *et al.*, 2012 \[[@B45-ijms-16-26135]\]                               *CDKN2B (9p21)*                       rs523096                                                                             Japanese                                                           GWAS                                                                                            D: 286/557\                                                     OR = 2.13, *p* =4.96 × 10^−11^                                                                    Associated with NTG
                                                                                                                                                                                                                                                                                                                                                                               R: 183/514                                                                                                                                                        

  Chen *et al.*, 2014 \[[@B46-ijms-16-26135]\]                                   *ABCA1 (9q31.1)*                      rs2487032                                                                            Asian Southern Chinese                                             GWAS                                                                                            D: 1007/1009\                                                   OR = 0.69, *p* = 1.66 × 10^−8^; OR~R~ = 0.73, *p*~R~ = 2.79 × 10^−9^                              --
                                                                                                                                                                                                                                                                                                                                                                               R: 1899/4965                                                                                                                                                      

  *PMM2 (16p13.2)*                                                               rs3785176                             OR = 1.42, *p* = 3.18 × 10^−6^; OR~R~ = 1.30, *p*~R~ = 5.77 × 10^−10^                --                                                                                                                                                                                                                                                                                                                                   

  Gharahkhani *et al.*, 2014 \[[@B47-ijms-16-26135]\]                            *ABCA1 (9q31.1)*                      rs2472493                                                                            D: Australian\                                                     GWAS                                                                                            D: 1155/1992\                                                   OR = 1.31, *p* = 2.1 × 10^−19^                                                                    --
                                                                                                                                                                                                            R1: Australian\                                                                                                                                                    R1: 932/6862\                                                                                                                                                     
                                                                                                                                                                                                            R2: US                                                                                                                                                             R2: 2616/2634                                                                                                                                                     

  *AFAP1 (4p16.1)*                                                               rs4619890                             OR = 1.20, *p* = 7.0 × 10^−10^                                                       --                                                                                                                                                                                                                                                                                                                                   

  *GMDS (6p25.3)*                                                                rs11969985                            OR = 1.31, *p* = 7.7 × 10^−10^                                                       --                                                                                                                                                                                                                                                                                                                                   

  Li *et al.*, 2015 \[[@B48-ijms-16-26135]\]                                     *CDKN2B-AS1 (9p21)*                   rs2157719                                                                            Asian, African and European                                        GWAS                                                                                            D: 3504/9746\                                                   OR = 0.71, *p* = 2.81 × 10^−33^                                                                   --
                                                                                                                                                                                                                                                                                                                                                                               R: 9173/26,780                                                                                                                                                    

  *CDC7-TGFBR3 (1p22)*                                                           rs1192415                             OR = 1.13, *p* = 1.60 × 10^−8^                                                       Associated with optical disk, vertical CD ratio                                                                                                                                                                                                                                                                                      

  *FNDC3B (3q25.31)*                                                             rs4894796                             OR = 0.89, *p* = 7.93 × 10^−8^ in Asians only                                        --                                                                                                                                                                                                                                                                                                                                   

  van Koolwijk *et al.*, 2012 \[[@B49-ijms-16-26135]\]                           *GAS7 (17p13.1)*                      rs11656696                                                                           D: NL\                                                             GWAS                                                                                            D: 11,972\                                                      *p* = 1.4 × 10^−8^\                                                                               Associated with IOP reduction
                                                                                                                                                                                                            R: UK, AU, Canada, NZ\                                                                                                                                             R: 7482\                                                        SNP: P = 2.4 × 10^−2^                                                                             
                                                                                                                                                                                                            SNP: NL, GE                                                                                                                                                        SNP: 1432                                                                                                                                                         

  *TMCO1 (1q24.1)*                                                               rs7555523                             *p* = 1.6 × 10^−8^\                                                                  Associated with IOP increase                                                                                                                                                                                                                                                                                                         
                                                                                                                       SNP: P = 9.1 × 10^−4^                                                                                                                                                                                                                                                                                                                                                                                                     

  Hysi *et al.*, 2014 \[[@B50-ijms-16-26135]\]                                   *FNDC3B (3q25.31)*                    rs6445055                                                                            Asian, European                                                    GWAS                                                                                            D: 35,296\                                                      *p* = 4.19 × 10^−8^                                                                               All 4 loci associated with IOP
                                                                                                                                                                                                                                                                                                                                                                               R: 4284/95,560                                                                                                                                                    

  *ABCA1 (9q31.1)*                                                               rs2472493                             *p* = 2.8 × 10^−11^                                                                                                                                                                                                                                                                                                                                                                                                       

  *ABO (9q34.2)*                                                                 rs8176693                             *p* = 6.39 × 10^−11^                                                                                                                                                                                                                                                                                                                                                                                                      

  *11p11.2*                                                                      rs747782                              *p* = 1.04 × 10^−11^                                                                                                                                                                                                                                                                                                                                                                                                      

  Chen *et al.*, 2015 \[[@B51-ijms-16-26135]\]                                   *FAR2 (12p11.22)*                     rs4931170                                                                            US Caucasian                                                       GWAS                                                                                            D: 1660                                                         *p* = 1.2 × 10^−5^                                                                                Associated with IOP

  *GGA3 (17q25.1)*                                                               rs52809447                            *p* = 6.7 × 10^−5^                                                                                                                                                                                                                                                                                                                                                                                                        

  *PKDREJ (22q13.31)*                                                            rs7291444                             *p* = 7.4 × 10^−5^                                                                                                                                                                                                                                                                                                                                                                                                        

  Springelkamp *et al.*, 2015 \[[@B52-ijms-16-26135]\]                           *ARHGEF12 (11q23.3)*                  rs58073046                                                                           D: NL\                                                             GWAS                                                                                            D: 8105\                                                        β = 0.44, *p* = 1.87 × 10^−8^\                                                                    Associated with increasing IOP
                                                                                                                                                                                                            R: NL, UK                                                                                                                                                          R: 1125/4117                                                    OR = 1.66, *p* = 2.81 × 10^−9^ (HPG)\                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                               OR = 1.29, *p* = 4.23 × 10^−2^ (NPG)                                                              

  Ramdas *et al.*, 2010 and 2011 \[[@B53-ijms-16-26135],[@B54-ijms-16-26135]\]   *ATOH7 (10q21.3-22.1)*                rs1900004                                                                            D: NL\                                                             GWAS                                                                                            D: 7360\                                                        β = −0.068, *p* = 2.05 × 10^−32^                                                                  Optic disc area (−)/VCDR (−)
                                                                                                                                                                                                            R: NL, UK                                                                                                                                                          R: 4455                                                                                                                                                           

  *CDC7/TGFBR3 (1p22)*                                                           rs1192415                             β = 0.064, *p* = 1.82 × 10^−27^                                                      Optic disc area (+)                                                                                                                                                                                                                                                                                                                  

  *CDKN2B (9p21)*                                                                rs1063192                             β = −0.014, *p* = 1.96 × 10^−14^                                                     VCDR (−)                                                                                                                                                                                                                                                                                                                             

  *SIX1 (14q22.3-q23)*                                                           rs10483727                            β =0.012, *p* = 9.30 × 10^−11^                                                       VCDR (+)                                                                                                                                                                                                                                                                                                                             

  *SALL1 (16q12.1)*                                                              rs1362756                             β = 0.028, *p* = 6.48 × 10^−8^                                                       Optic disc area (+)                                                                                                                                                                                                                                                                                                                  

  Macgregor *et al.*, 2010 \[[@B55-ijms-16-26135]\]                              *ATOH7 (10q21.3-22.1)*                rs3858145                                                                            D: AU\                                                             GWAS                                                                                            D: 1368\                                                        *p* = 3.4 × 10^−10^                                                                               Associated with mean disc area
                                                                                                                                                                                                            R: UK                                                                                                                                                              R: 848                                                                                                                                                            

  *RFTN1* *(3p24)*                                                               rs690037                              *p* = 1.6 × 10^−6^                                                                   Explained 2.1% cup area variation in AU cohort                                                                                                                                                                                                                                                                                       

  Khor *et al.*, 2011 \[[@B56-ijms-16-26135]\]                                   *CARD10 (22q13.1)*                    rs9607469                                                                            D: Asian\                                                          GWAS                                                                                            D: 4445\                                                        *p* = 2.73 × 10^−12^                                                                              Associated with optic disc area
                                                                                                                                                                                                            R: NL                                                                                                                                                              R: 9326                                                                                                                                                           

  *ATOH7 (10q21.3-22.1)*                                                         rs7916697                             *p* = 2.00 × 10^−15^                                                                 Associated with optic disc area in Asians                                                                                                                                                                                                                                                                                            

  *CDC7/TGFBR3 (1p22)*                                                           rs1192415                             *p* = 7.57 × 10^−17^                                                                                                                                                                                                                                                                                                                                                                                                      

  Iglesias *et al.*, 2014 \[[@B57-ijms-16-26135] \]                              *SIX6 (14q23)*                        rs33912345 (His141Asn)                                                               D: NL, UK\                                                         GWAS                                                                                            D: 292/1208\                                                    *p* = 7.74 × 10^−7^                                                                               Associated with VCDR and POAG
                                                                                                                                                                                                            R: NL, UK                                                                                                                                                          R: 11,473                                                                                                                                                         

  rs146737847 (Glu29Lys)                                                         *p* = 5.0 × 10^−3^                    Associated with VCDR                                                                                                                                                                                                                                                                                                                                                                                                      

  Vitart *et al.*, 2010 \[[@B58-ijms-16-26135]\]                                 *COL5A1 9q34.2*                       rs1536482                                                                            Croatia, Scotland                                                  GWAS                                                                                            D: 7711\                                                        β = 0.22, *p* = 7.1 × 10^−8^                                                                      Associated with CCT
                                                                                                                                                                                                                                                                                                                                                                               R: 2681                                                                                                                                                           

  *ZNF469 16q24.2*                                                               rs12447690                            β = 0.23, *p* = 4.4 × 10^−9^                                                                                                                                                                                                                                                                                                                                                                                              

  *AKAP13 15q24-25*                                                              rs6496932                             β = 0.13, *p* = 1.4 × 10^−8^                                                                                                                                                                                                                                                                                                                                                                                              

  *AVGR8 13q12.11*                                                               rs1034200                             β = 0.14, *p* = 3.5 × 10^−9^                                                                                                                                                                                                                                                                                                                                                                                              

  Vithana *et al.*, 2011 \[[@B59-ijms-16-26135]\]                                *ZNF469 (16q24)*                      rs12447690                                                                           D1: SG-Malay D2: SG-Chinese                                        GWAS                                                                                            D1: 3280\                                                       β = −5.068, *p* = 1.92 × 10^−14^                                                                  Associated with CCT
                                                                                                                                                                                                                                                                                                                                                                               D2: 3400                                                                                                                                                          

  rs9938149                                                                      β = −6.248, *p* = 1.63 × 10^−16^                                                                                                                                                                                                                                                                                                                                                                                                                                

  *COL5A1/RXRA (9q34.2-q34.3)*                                                   rs1536478                             β = −4.63, *p* = 3.05 × 10^−9^                                                                                                                                                                                                                                                                                                                                                                                            

  rs7044529                                                                      β = 2.7, *p* = 1.2 × 10^−4^                                                                                                                                                                                                                                                                                                                                                                                                                                     

  *COL8A2 (1p34.2)*                                                              rs96067                               β = −4.799, *p* = 5.40 × 10^−13^                                                                                                                                                                                                                                                                                                                                                                                          

  Ulmer *et al.*, 2012 \[[@B60-ijms-16-26135]\]                                  *ZNF469 (16q24)*                      rs12447690                                                                           D: US-Cau\                                                         GWAS                                                                                            D: 1117\                                                        β = −5.08, *p* = 0.001                                                                            Associated with CCT
                                                                                                                                                                                                            SNP: US-Cau                                                                                                                                                        SNP: 6469                                                                                                                                                         

  *NTM (11q25)*                                                                  rs7481514                             β = −6.89, *p* = 1.03 × 10^−5^                                                       Associated with reduced CCT                                                                                                                                                                                                                                                                                                          

  OR = 1.28, *p* = 9.9 × 10^−4^                                                  and POAG risk in low-tension subset                                                                                                                                                                                                                                                                                                                                                                                                                             

  **Candidate Gene Studies**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Chen *et al.*, 2012 \[[@B61-ijms-16-26135]\]                                   *2p16.3*                              rs1533428                                                                            China                                                              SNP                                                                                             462/577                                                         OR = 2.16, *p* = 0.00025                                                                          Associated with late-onset POAG

  Kim *et al.*, 2014 \[[@B62-ijms-16-26135]\]                                    *10p12.31*                            rs7098387                                                                            Korea                                                              SNP                                                                                             211/904                                                         OR = 2.0, *p* = 0.00038                                                                           Associated with POAG

  Fan *et al.*, 2005 \[[@B63-ijms-16-26135]\]                                    *APOE 19q13.2*                        rs429358\                                                                            Japan                                                              SNP                                                                                             400/281                                                         OR = 0.4, *p* = 0.007                                                                             APOE4 confers a protective effect against NTG
                                                                                                                       rs7412                                                                                                                                                                                                                                                                                                                                                                                                                    

  Lam *et al.*, 2006 \[[@B64-ijms-16-26135]\]                                    rs429358\                             China                                                                                SNP                                                                400/300                                                                                         OR = 0.36, *p* = 0.008                                          APOE4 confers a protective effect against NTG                                                     
                                                                                 rs7412                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Lake *et al.*, 2004 \[[@B65-ijms-16-26135]\]                                   rs429358\                             UK                                                                                   SNP                                                                155/349                                                                                         *p* = ns                                                        None                                                                                              
                                                                                 rs7412                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    *ATOH7 10q21.3-22.1*                  rs7916697                                                                            African-Caribbean                                                  SNP                                                                                             272/165                                                         OR = 0.67, *p* = 0.0096                                                                           Interacts with rs1063192 near *CDKN2B* to reduce POAG risk

  rs1900004                                                                      OR = 1.02, *p* = 0.9076               None                                                                                                                                                                                                                                                                                                                                                                                                                      

  rs3858145                                                                      OR = 0.98, *p* = 0.9138               None                                                                                                                                                                                                                                                                                                                                                                                                                      

  Mabuchi *et al.*, 2012 \[[@B67-ijms-16-26135]\]                                rs1900004                             Japan                                                                                SNP                                                                425/191                                                                                         *p* = 0.028                                                     Associated with NTG                                                                               

  Chen *et al.*, 2012 \[[@B68-ijms-16-26135]\]                                   rs3858145                             China                                                                                SNP                                                                142/289                                                                                         OR = 2.69, *p* \< 0.05                                          Showed interaction with RFTN1 rs690037                                                            

  rs61854782                                                                     β = −0.088, *p* = 0.004               Associated with VCDR in controls but not POAG                                                                                                                                                                                                                                                                                                                                                                             

  Fan *et al.*, 2011 \[[@B69-ijms-16-26135]\]                                    rs1900004                             US-Caucasian                                                                         SNP                                                                539/336                                                                                         OR = 1.89, *p* = 0.025                                          Associated with increased optic nerve area                                                        

  Dimasi *et al.*, 2012 \[[@B70-ijms-16-26135]\]                                 rs1900004                             AU, NZ                                                                               SNP                                                                873/886                                                                                         OR = 1.12′, *p* = 0.18                                          No association                                                                                    

  rs3858145                                                                      OR = 1.13, *p* = 0.12                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Wiggs *et al.*, 2011 \[[@B71-ijms-16-26135]\]                                  *CAV1/CAV2 7q31.1*                    rs4236601                                                                            US-Caucasian                                                       SNP                                                                                             1000/1183                                                       OR = 1.31, *p* = 0.0007                                                                           Significantly associated in women more than men

  rs1052990                                                                      OR = 1.25, *p* = 0.0084               Significantly associated in women; and nominally associated with NPG (*p* = 0.039)                                                                                                                                                                                                                                                                                                                                        

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    rs4236601                             African-Caribbean                                                                    SNP                                                                272/165                                                                                         OR = 1.15, *p* = 0.3332                                         No association                                                                                    

  Loomis *et al.*, 2014 \[[@B72-ijms-16-26135]\]                                 rs4236601                             US-Caucasian                                                                         SNP                                                                R1: 976/2132\                                                                                   *p*~meta~ = 2.61 × 10^(−7)^, *p*~women~ = 1.59 × 10^(−5)^       Associated with early paracentral VF defect                                                       
                                                                                                                                                                                                                                                                               R2: 1140/2290                                                                                                                                                                                                                                                     

  rs17588172                                                                     *p*~meta~ = 1.07 × 10^(−4)^           Associated with early paracentral VF defect                                                                                                                                                                                                                                                                                                                                                                               

  Kuehn *et al.*, 2011 \[[@B73-ijms-16-26135]\]                                  rs4236601                             US                                                                                   SNP                                                                545/297                                                                                         *p* = 0.5                                                       No association                                                                                    

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    *CARD10 22q13.1*                      rs9607469                                                                            African-Caribbean                                                  SNP                                                                                             272/165                                                         OR = 1.13, *p* = 0.5096                                                                           No association

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    *CDC7/TGFBR3 1p22*                    rs1192415                                                                            African-Caribbean                                                  SNP                                                                                             272/165                                                         OR = 1.14, *p* = 0.4802                                                                           No association

  Dimasi *et al.*, 2012 \[[@B70-ijms-16-26135]\]                                 rs1192415                             AU, NZ                                                                               SNP                                                                873/886                                                                                         OR = 1.22, *p* = 0.03                                           Showed nominal significance with optic disc area                                                  

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    *CDKN2B (-AS1) 9p21*                  rs1063192                                                                            African-Caribbean                                                  SNP                                                                                             272/165                                                         OR = 0.39, *p* = 0.0008                                                                           Minor allele was protective against POAG

  rs4977756                                                                      OR = 0.89, *p* = 0.4507               No association                                                                                                                                                                                                                                                                                                                                                                                                            

  Fan *et al.*, 2011 \[[@B69-ijms-16-26135]\]                                    rs1063192                             US-Caucasian                                                                         SNP                                                                539/336                                                                                         OR = 0.73, *p* = 0.0006                                         Associated with decreased VCDR and POAG risk                                                      

  Mabuchi *et al.*, 2012 \[[@B67-ijms-16-26135]\]                                rs1063192                             Japan                                                                                SNP                                                                425/191                                                                                         β = 0.11, *p* = 0.0043                                          Associated with VCDR; and NTG (*p* = 0.023)                                                       

  Dimasi *et al.*, 2012 \[[@B70-ijms-16-26135]\]                                 rs1063192                             AU, NZ                                                                               SNP                                                                873/886                                                                                         OR = 0.74, *p* = 2.2 × 10^−5^                                   More strongly associated with advanced open-angle glaucoma                                        

  Burdon *et al.*, 2012 \[[@B74-ijms-16-26135]\]                                 rs10120688 rs7049105                  AU, NZ                                                                               SNP                                                                1432/595                                                                                        VCDR -- β = 0.016, *p* = 0.03; IOP -- β = −2.135, *p* = 0.001   Associated with larger VCDR and lower IOP                                                         

  Mabuchi *et al.*, 2012 \[[@B67-ijms-16-26135]\]                                *CHEK2 22q12.1*                       rs1547014                                                                            Japan                                                              SNP                                                                                             425/191                                                         β = 0.11, *p* = 0.0079                                                                            Associated with VCDR; and HTG (*p* = 0.013)

  Dimasi *et al.*, 2012 \[[@B70-ijms-16-26135]\]                                 rs1547014                             AU, NZ                                                                               SNP                                                                873/886                                                                                         OR = 0.98, *p* = 0.77                                           No association                                                                                    

  Dimasi *et al.*, 2012 \[[@B70-ijms-16-26135]\]                                 *COL5A1/RXRA 9q34.2-q34.3*            rs1536482                                                                            AU, NZ                                                             SNP                                                                                             873/886                                                         OR = 0.94, *p* = 0.46                                                                             No association

  rs7044529                                                                      OR = 1.00, *p* = 0.98                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Desronvil *et al.*, 2010 \[[@B75-ijms-16-26135]\]                              *COL8A2 1p34.2*                       rs274754                                                                             US-Caucasian                                                       SNP                                                                                             100                                                             *p* = 0.018                                                                                       Associated with corneal thickness

  Dimasi *et al.*, 2010 \[[@B76-ijms-16-26135]\]                                 *FBN1 15q21.1*                        rs17352842                                                                           AU-Caucasian                                                       SNP                                                                                             956                                                             *p* = 0.02                                                                                        Associated with CCT

  Rocha *et al.*, 2011 \[[@B77-ijms-16-26135]\]                                  *GSTT1/GSTM1 1p13.3*                  null \> positive                                                                     Brazil                                                             SNP                                                                                             87/85                                                           OR = 2.4, *p* = 0.016                                                                             T1M0 genotype associated with higher IOP and severe defect of right eye optic nerve and visual field

  Juronen *et al.*, 2000 \[[@B78-ijms-16-26135]\]                                positive \> null                      Estonia                                                                              SNP                                                                250/202                                                                                         OR = 1.83, *p* = 0.002                                          GSTM1 were at significant risk for glaucoma and even higher in smokers (OR = 3.86, *p* = 0.012)   

  Jansson *et al.*, 2003 \[[@B79-ijms-16-26135]\]                                positive = null                       Sweden                                                                               SNP                                                                200/200                                                                                         *p* = ns                                                        No association                                                                                    

  Fan *et al.*, 2010 \[[@B80-ijms-16-26135]\]                                    positive = null                       China                                                                                SNP                                                                405/201                                                                                         *p* = ns                                                        No association                                                                                    

  Liu *et al.*, 2010 \[[@B81-ijms-16-26135]\]                                    *NTF4 19q13.33*                       Whole gene                                                                           US-Caucasian                                                       SNP                                                                                             443/533                                                         --                                                                                                Not associated with POAG

  Rao *et al.*, 2010 \[[@B82-ijms-16-26135]\]                                    Whole gene                            India                                                                                SNP                                                                141/285                                                                                         *p* = 0.2                                                       No association                                                                                    

  Vithana *et al.*, 2010 \[[@B83-ijms-16-26135]\]                                c.338T\>C                             China                                                                                SNP                                                                174/91                                                                                          --                                                              Rare cause of POAG in Chinese                                                                     

  Chen *et al.*, 2012 \[[@B84-ijms-16-26135]\]                                   c.470G\>C c.545C\>T                   China                                                                                SNP                                                                720/230                                                                                         --                                                              May be a rare cause of POAG                                                                       

  Aung *et al.*, 2002 \[[@B85-ijms-16-26135]\]                                   *OPA1 3q28-q29*                       rs166850                                                                             UK                                                                 SNP                                                                                             163/86                                                          OR = 3.1, *p* = 0.002                                                                             rs166850 combined with rs10451941 was more strongly associated with NTG (*p* = 0.00001)

  rs10451941                                                                     *p* = 0.03                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Mabuchi *et al.*, 2007 \[[@B86-ijms-16-26135]\]                                rs10451941                            Japan                                                                                SNP                                                                285/185                                                                                         OR = 2.27, *p* = 0.004                                          Increased risk of NTG; and age at diagnosis in HTG (*p* = 0.048)                                  

  Yao *et al.*, 2006 \[[@B87-ijms-16-26135]\]                                    rs166850 rs10451941                   African-Caribbean                                                                    SNP                                                                109/48                                                                                          *p* = ns                                                        No association                                                                                    

  Fan *et al.*, 2010 \[[@B80-ijms-16-26135]\]                                    rs166850 rs10451941                   China                                                                                SNP                                                                405/201                                                                                         *p* = ns                                                        No association                                                                                    

  Dimasi *et al.*, 2010 \[[@B76-ijms-16-26135]\]                                 *PAX6 11p13*                          rs3026398                                                                            AU-Caucasian                                                       SNP                                                                                             956                                                             *p* = 0.02                                                                                        Associated with CCT; more strongly with rs662702 haplotype (*p* = 0.009)

  Chen *et al.*, 2012 \[[@B61-ijms-16-26135]\]                                   *PLXDC2 10p12.31*                     rs7081455                                                                            China                                                              SNP                                                                                             462/577                                                         OR = 1.25, *p* = 0.31                                                                             No association

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    rs7081455                             African-Caribbean                                                                    SNP                                                                272/165                                                                                         OR = 1.04, *p* = 0.8052                                         No association                                                                                    

  Chen *et al.*, 2012 \[[@B68-ijms-16-26135]\]                                   *RFTN1 3p24.3*                        rs3858145                                                                            China                                                              SNP                                                                                             142/289                                                         β = 25.66, *p* = 0.029                                                                            Associated with CCT

  Fan *et al.*, 2011 \[[@B69-ijms-16-26135]\]                                    *SIX1/SIX6 14p22-23*                  rs10483727                                                                           US-Caucasian                                                       SNP                                                                                             539/336                                                         OR = 1.33, *p* = 0.0043                                                                           Associated with increased VCDR and POAG risk

  Dimasi *et al.*, 2012 \[[@B70-ijms-16-26135]\]                                 rs10483727                            AU, NZ                                                                               SNP                                                                873/886                                                                                         OR = 1.38, *p* = 6.2 × 10^−6^                                   Strongly associated with open-angle glaucoma                                                      

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    rs10483727                            African-Caribbean                                                                    SNP                                                                272/165                                                                                         OR = 0.77, *p* = 0.4151                                         No association                                                                                    

  Mabuchi *et al.*, 2012 \[[@B67-ijms-16-26135]\]                                rs10483727                            Japan                                                                                SNP                                                                425/191                                                                                         *p* = 0.017                                                     Associated with age at diagnosis in NTG                                                           

  Carnes *et al.*, 2014 \[[@B88-ijms-16-26135]\]                                 rs10483727                            US---Caucasians                                                                      SNP                                                                262/256                                                                                         OR = 1.32, *p* = 3.87 × 10^−11^                                 Significantly associated with POAG                                                                

  rs33912345                                                                     SNP                                   OR = 1.27, *p* = 4.2 × 10^−10^                                                       Associated with POAG; and thickness of retinal nerve fiber layer                                                                                                                                                                                                                                                                     

  Mabuchi *et al.*, 2011 \[[@B89-ijms-16-26135]\]                                *SRBD1 2p21*                          rs3213787                                                                            Japan                                                              SNP                                                                                             370/191                                                         *p* = 0.0003 in NTG and *p* = 0.0013 in HTG                                                       Associated with HTG and NTG including late-onset

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    rs3213787                             African-Caribbean                                                                    SNP                                                                272/165                                                                                         OR = 0.45, *p* = 0.2882                                         None                                                                                              

  Takano *et al.*, 2012 \[[@B90-ijms-16-26135]\]                                 *TLR4 9q33.1*                         rs2149356                                                                            Japan                                                              SNP                                                                                             449/107                                                         *p* = 0.000058                                                                                    Associated with NTG

  Chen *et al.*, 2012 \[[@B61-ijms-16-26135]\]                                   rs7037117                             China                                                                                SNP                                                                462/577                                                                                         OR = 0.99, *p* = 0.99                                           No association                                                                                    

  Shibuya *et al.*, 2008 \[[@B91-ijms-16-26135]\]                                rs7037117                             Japan                                                                                SNP                                                                215/318                                                                                         *p* = 0.0095                                                    1.47- to 1.65-fold increased risk of NTG; strongest association with rs10759930 haplotype         

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    rs7037117                             African-Caribbean                                                                    SNP                                                                272/165                                                                                         OR = 0.73, *p* = 0.0571                                         No association                                                                                    

  Sharma *et al.*, 2012 \[[@B92-ijms-16-26135]\]                                 *TMCO1 1q24*                          rs4656461                                                                            AU, NZ                                                             SNP                                                                                             1420                                                            β = −2.56, *p* = 0.004                                                                            Correlation with age at diagnosis

  Ozel *et al.*, 2014 \[[@B93-ijms-16-26135]\]                                   rs7518099                             US-Caucasian                                                                         SNP                                                                6.236                                                                                           *p* = 8 × 10^−8^                                                Strongly associated with IOP                                                                      

  Chen *et al.*, 2012 \[[@B61-ijms-16-26135]\]                                   *TMTC2 12q21.31*                      rs7961953                                                                            China                                                              SNP                                                                                             462/577                                                         OR = 1.15, *p* = 0.35                                                                             No association

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    rs7961953                             African-Caribbean                                                                    SNP                                                                272/165                                                                                         OR = 0.89, *p* = 0.5559                                         No association                                                                                    

  Fan *et al.*, 2010 \[[@B80-ijms-16-26135]\]                                    *TNF*α *6p21.3*                       rs1800629                                                                            China                                                              SNP                                                                                             405/201                                                         *p* = 0.012                                                                                       Associated with HTG

  Wang *et al.*, 2012 \[[@B94-ijms-16-26135]\]                                   rs4645836                             China                                                                                SNP                                                                234/230                                                                                         OR = 0.63, *p* = 0.017                                          Protective for POAG                                                                               

  Mossböck *et al.*, 2006 \[[@B95-ijms-16-26135]\]                               rs1800629                             AU                                                                                   SNP                                                                114/228                                                                                         OR = 0.96, *p* \> 0.05                                          Not associated among Caucasian                                                                    

  rs361525                                                                       OR = 0.52, *p* \> 0.05                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Rao *et al.*, 2010 \[[@B82-ijms-16-26135]\]                                    *VAV2 9q34.1*                         rs2156323                                                                            India                                                              SNP                                                                                             141/285                                                         *p* = 0.533                                                                                       No association

  *VAV3 1p13.3*                                                                  rs2801219                             *p* = 0.133                                                                                                                                                                                                                                                                                                                                                                                                               

  Dimasi *et al.*, 2012 \[[@B70-ijms-16-26135]\]                                 *ZNF469 16q24*                        rs12447690                                                                           AU, NZ                                                             SNP                                                                                             873/886                                                         OR = 1.01, *p* = 0.91                                                                             No association

  rs9938149                                                                      OR = 0.94, *p* = 0.46                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Chen *et al.*, 2012 \[[@B61-ijms-16-26135]\]                                   *ZP4 1q43*                            rs693421                                                                             China                                                              SNP                                                                                             462/577                                                         OR = 0.98, *p* = 0.31                                                                             No association

  Cao *et al.*, 2012 \[[@B66-ijms-16-26135]\]                                    rs547984                              African-Caribbean                                                                    SNP                                                                272/165                                                                                         OR = 1.05, *p* = 0.7374                                         No association                                                                                    

  Kim *et al.*, 2014 \[[@B62-ijms-16-26135]\]                                    rs693421                              Korea                                                                                SNP                                                                211/904                                                                                         OR = 1.4, *p* = 0.0082                                          Associated with POAG                                                                              

  Li *et al.*, 2015 \[[@B48-ijms-16-26135]\]                                     *CDKN2B-AS1 9p21*                     rs2157719                                                                            Saudi Arabia                                                       SNP                                                                                             R \*\*: 236/655                                                 OR = 1.24, *p* = 0.146                                                                            --

  *CDC7-TGFBR3 1p22*                                                             rs1192415                             OR = 1.24, *p* = 0.146                                                               --                                                                                                                                                                                                                                                                                                                                   

  *FNDC3B 3q25.31*                                                               rs4894796                             OR = 1.03, *p* = 0.779                                                               --                                                                                                                                                                                                                                                                                                                                   

  Neamatzadeh *et al.*, 2015 \[[@B96-ijms-16-26135]\]                            *TP53 17p13.1*                        rs1042522                                                                            Iranian                                                            SNP                                                                                             65/65                                                           OR = 2.1, *p* \< 0.05                                                                             Pro72 allele is associated with POAG risk

  Emam *et al.*, 2014 \[[@B97-ijms-16-26135]\]                                   *NOS3 7q36*                           rs2070744                                                                            Egypt                                                              SNP                                                                                             160/110                                                         OR = 1.86, *p* \< 0.0001                                                                          rs2070744 is associated with high tension glaucoma; and with plasma nitrite/nitrate levels (*p* \< 0.001)

  rs1799983                                                                      --                                    OR = 1.28, *p* = 0.21                                                                --                                                                                                                                                                                                                                                                                                                                   

  27 bp-VNTR-a/b                                                                 --                                    OR = 0.81, *p* = 0.33                                                                --                                                                                                                                                                                                                                                                                                                                   

  Abu-Amero *et al.*, 2013 \[[@B98-ijms-16-26135]\]                              *CAT 11p13*                           rs1001179                                                                            Saudi Arabia                                                       SNP                                                                                             225/403                                                         OR = 0.81, *p* = 0.218                                                                            Associated with age of onset, and trend towards IOP, and duration of glaucoma

  Abu-Amero *et al.*, 2014 \[[@B99-ijms-16-26135]\]                              *SOD2 6q25.3*                         rs4880                                                                               Saudi Arabia                                                       SNP                                                                                             226/403                                                         OR = 1.0, *p* = 0.988                                                                             Trend towards age of onset and IOP

  Abu-Amero *et al.*, 2012 \[[@B100-ijms-16-26135]\]                             *CAV1/CAV2 7q31*                      rs4236601                                                                            Saudi Arabia                                                       SNP                                                                                             220/405                                                         OR = 1.06, *p* = 0.699                                                                            --

  Abu-Amero *et al.*, 2012 \[[@B101-ijms-16-26135]\]                             *LOXL1 15q24.1*                       rs1048661                                                                            Saudi Arabia                                                       SNP                                                                                             96/101                                                          *p* = 0.866                                                                                       --

  rs3825942                                                                      --                                    *p* = 0.477                                                                          --                                                                                                                                                                                                                                                                                                                                   

  rs2165241                                                                      --                                    *p* = 0.176                                                                          --                                                                                                                                                                                                                                                                                                                                   

  Abu-Amero *et al.*, 2006 \[[@B102-ijms-16-26135]\]                             *MYOC 1q24.3*                         22259 G/T (G324V)                                                                    Saudi Arabia                                                       SNP                                                                                             27/96                                                           *p* = 0.74                                                                                        --

  *OPTN 10p13*                                                                   412 G/A (T34T)                        --                                                                                   *p* = 0.61                                                         --                                                                                                                                                                                                                                                                

  469 G/C (Q53H)                                                                 --                                    *p* = 0.28                                                                           --                                                                                                                                                                                                                                                                                                                                   

  Zanon-Moreno *et al.*, 2013 \[[@B103-ijms-16-26135]\]                          *SLC23A2 20p13*                       rs1279683                                                                            Mediterranean                                                      SNP                                                                                             250/250                                                         OR = 2.47, *p* \< 0.001                                                                           Associated with POAG risk; and plasma vitamin C levels (*p* \< 0.001)

  *TTPA 8q12.3*                                                                  rs6994076                             --                                                                                   OR = 1.38, *p* = 0.122                                             Associated with plasma vitamin E levels (*p* \< 0.001)                                                                                                                                                                                                            

  *SEC14L2/TAP 22q12.2*                                                          rs737723                              --                                                                                   OR = 2.24, *p* \< 0.001                                            Associated with POAG risk; and nominal (*p* = 0.047) gene-gene interaction with SNP rs1279683                                                                                                                                                                     

  *GPX4 19p13.3*                                                                 rs757228                              --                                                                                   OR = 0.80, *p* = 0.337                                             --                                                                                                                                                                                                                                                                

  Zanon-Moreno *et al.*, 2011 \[[@B104-ijms-16-26135]\]                          *RBP1 3q23*                           rs176990                                                                             Mediterranean                                                      SNP                                                                                             150/150                                                         OR = 0.97, *p* = 0.826                                                                            --

  rs190910                                                                       --                                    OR = 0.83, *p* = 0.315                                                               --                                                                                                                                                                                                                                                                                                                                   

  *SLC23A1 5q31.2*                                                               rs10063949                            --                                                                                   OR = 1.19, *p* = 0.552                                             --                                                                                                                                                                                                                                                                

  *SLC23A2 20p13*                                                                rs1279683                             --                                                                                   OR = 1.67, *p* = 0.010                                             Associated with POAG risk; and plasma vitamin C levels (*p* \< 0.001)                                                                                                                                                                                             

  Abu-Amero *et al.*, 2008 \[[@B105-ijms-16-26135]\]                             *GSTT1/GSTM1 1p13.3*                  T0M0                                                                                 Saudi Arabia                                                       SNP                                                                                             49/120                                                          OR = 5.67, *p* = 0.06                                                                             GSTT1 and GSTM1 positive genotypes are at risk for POAG

  T1M0                                                                           --                                    OR = 10.2, *p* = 0.00001                                                             --                                                                                                                                                                                                                                                                                                                                   

  T0M1                                                                           --                                    OR = 11.3, *p* = 0.00001                                                             --                                                                                                                                                                                                                                                                                                                                   

  Unal *et al.*, 2007 \[[@B106-ijms-16-26135]\]                                  *GSTT1/GSTM1 1p13.3*                  T0M1                                                                                 Turkey                                                             SNP                                                                                             144/121                                                         OR = 3.46, *p* \< 0.005                                                                           GSTM1 positive and GSTT1 null genotypes are associated with increased risk of POAG

  Al-Dabbagh *et al.* \[[@B107-ijms-16-26135]\]                                  *APOE 19q13.2*                        rs429358\                                                                            Saudi Arabia                                                       SNP                                                                                             60/130                                                          OR = 2.75, *p* = 0.034                                                                            *APOE4* allele is a risk factor for POAG
                                                                                                                       rs7412                                                                                                                                                                                                                                                                                                                                                                                                                    

  Saglar *et al.*, 2009 \[[@B108-ijms-16-26135]\]                                *APOE 19q13.2*                        rs429358\                                                                            Turkey                                                             SNP                                                                                             75/119                                                          *p* = 0.38                                                                                        --
                                                                                                                       rs7412                                                                                                                                                                                                                                                                                                                                                                                                                    

  *TP53 17p*                                                                     rs1042522                             --                                                                                   *p* = 0.12                                                         --                                                                                                                                                                                                                                                                

  Nilforoushan *et al.* \[[@B109-ijms-16-26135]\]                                *MTHFR 1p36.3*                        rs1801133                                                                            Iran                                                               --                                                                                              73/90                                                           *p* = 0.337                                                                                       --
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* AU---Australia; CCT---central corneal thickness; D---discovery cohort; GE---Germany; HPG---high-pressure glaucoma; HTG---high-tension glaucoma; IOP---intraocular pressure; POAG---primary open angle glaucoma; NPG---normal-pressure glaucoma; NTG---normal-tension glaucoma; NL---Netherland; NZ---New Zealand; R---replication cohort; SG---Singapore; SW---Sweden; UK---United Kingdom; US---United States; VCDR---vertical cup-to-disc ratio. \*\* Part of an International Glaucoma Genetics Consortium Replication Study.

4. GWAS and POAG {#sec4-ijms-16-26135}
================

Nakano *et al.* described the first GWAS in the Japanese POAG population with patients predominantly having NTG \[[@B38-ijms-16-26135]\]. This was a two-stage GWAS involving a discovery cohort and a replication cohort. The study reported significant loci on chromosomes 1, 10 and 12 that included genes such as *ZP4*, *PLXDC2* and *TMCT2* (*DKFZp762A217*), respectively. However, none of the SNPs achieved a genome-wide significance (*p* \< 5 × 10^−8^) even in the combined analysis and, therefore, they await further evaluation in additional cohorts. Meguro *et al.* reported the first genome-wide significant (*p* = 2.5 × 10^−9^, odds ratio (OR) = 2.80) association for SNP rs3213787 in *SRBD1* in the Japanese NTG population \[[@B39-ijms-16-26135]\]. Two other studies have replicated this finding in a Japanese NTG and high-tension glaucoma (HTG) cohort \[[@B89-ijms-16-26135]\] and a US Caucasian POAG cohort \[[@B110-ijms-16-26135]\], but not in the African-Caribbean cohort \[[@B66-ijms-16-26135]\].

GWASs have been able to identify certain common variants that are of significance to the understanding of POAG pathogenesis. These include SNPs near *CAV1* and *CAV2* in an Icelandic cohort \[[@B40-ijms-16-26135]\], in *TMCO1* and *CDKN2B*-*AS1* in an Australian cohort \[[@B41-ijms-16-26135]\], in *CDKN2B-AS1*, *SIX1/SIX6*, and the 8q22 locus in Europeans \[[@B42-ijms-16-26135]\], in *GAS7* and *TMCO1* in US Caucasians \[[@B49-ijms-16-26135]\], and in *CDKN2B-AS1*, *CDC7/TGFBR3* and *FNDC3B* in Asian, African and European cohorts \[[@B48-ijms-16-26135]\].

The *caveolin* genes have been postulated to influence transforming growth factor-beta (TGF-β) or nitric oxide signaling pathways involved in POAG pathogenesis. The locus on chromosome 7q31 has been studies in US Caucasians, Africans, and the Saudi Arabian population with inconsistent results \[[@B40-ijms-16-26135],[@B66-ijms-16-26135],[@B71-ijms-16-26135],[@B72-ijms-16-26135],[@B73-ijms-16-26135],[@B100-ijms-16-26135]\]. A recent meta-analysis of five studies, including 5774 POAG cases and 40,598 healthy controls, suggested that SNP rs4236601 is associated with POAG risk in Caucasian and Asian populations but not in African and Saudi populations \[[@B111-ijms-16-26135]\]. Australian GWAS identified two loci, *TMCO1* (1q24) and *CDKN2B*-*AS1* (9p21), to be associated with advanced glaucoma. The association of the *TMCO1* locus with POAG has been replicated in another GWAS for a Caucasian cohort \[[@B49-ijms-16-26135]\], and associated with increase in IOP as well \[[@B49-ijms-16-26135],[@B93-ijms-16-26135]\]; the carriers of risk alleles for SNP rs4656461 have been reported to be associated with a younger age at diagnosis \[[@B92-ijms-16-26135]\]. The ciliary body, trabecular meshwork and retina show abundant TMCO1 expression. However, its precise role in POAG pathogenesis is unclear. So far, there are no published reports of association studies at the *TMCO1* locus in the Middle East population.

Since the identification of the association between the *CDKN2B/CDKN2B-AS1* locus and POAG in the Australian cohort, several GWASs have replicated this association in the US Caucasian \[[@B42-ijms-16-26135]\], Japanese \[[@B43-ijms-16-26135],[@B44-ijms-16-26135],[@B45-ijms-16-26135]\], Asian, African, and European populations \[[@B48-ijms-16-26135]\], providing strong evidence for the association of this locus with POAG. In addition, many studies have reported a positive association of SNPs in *CDKN2B* in several other populations using a candidate-gene approach \[[@B66-ijms-16-26135],[@B67-ijms-16-26135],[@B69-ijms-16-26135],[@B70-ijms-16-26135],[@B74-ijms-16-26135]\]. These SNPs are located in an anti-sense non-protein coding gene, *CDKN2BAS*, within the *CDKN2A*/*B* gene cluster. CDKN2B is a tumor suppressor gene and, with its suggested role in the TGF-β pathway, may play a critical role in glaucoma pathogenesis \[[@B112-ijms-16-26135],[@B113-ijms-16-26135]\]. Interestingly, carriers of the *CDKN2B-AS1* risk alleles are associated with larger VCDR \[[@B53-ijms-16-26135],[@B54-ijms-16-26135]\] and low IOP as compared to the wild-type carriers \[[@B74-ijms-16-26135]\]. On the basis of these findings, it has been suggested that the *CDKN2B/CDKN2B-AS1* locus of 9p21 may possibly predispose a person to glaucomatous optic neuropathy in a mechanism that may not be dependent on IOP and highlights the importance of the chromosome 9p21 susceptibility locus as a risk factor in the development of POAG \[[@B114-ijms-16-26135]\].

Recently, Li *et al.* performed a GWAS on 3504 POAG cases and 9746 controls. The positive significant findings of this phase were then replicated in 9173 POAG cases and 26,780 controls across 18 different collections of Asian, African, and European populations including a replication cohort from our center in Saudi Arabia \[[@B48-ijms-16-26135]\]. The study confirmed and provided strong evidence of an association at the *CDKN2B-AS1* locus (rs2157719, OR = 0.71, *p* = 2.81 × 10^−33^), and also identified SNP rs1192415 in the *CDC7-TGFBR3* gene (1p22) showing significant association with POAG (OR = 1.13, *p* = 1.60 × 10^−8^) in the Asian, African and European populations, as well as SNP rs4894796 in *FNDC3B* (3q25.31) showing a significant association in Asians only (OR = 0.89, *p* = 7.93 × 10^−8^). Interestingly, these results were found to be non-significant in the Saudi replication cohort, indicating that the genetic cause for POAG in the Saudi population may be different than those from Asian, African and European descent.

GWAS studies by Wiggs *et al.* and Osman *et al.* in the Caucasian POAG and Japanese POAG cases, respectively, have demonstrated a strong association of SNP rs10483727 located in the in the intergenic region between the *SIX1* and *SIX6* locus (14q23) \[[@B42-ijms-16-26135],[@B43-ijms-16-26135]\]. SIX6 has been shown to express in the developing and adult human retina \[[@B115-ijms-16-26135]\]. Moreover, the association of SNP rs10483727 in the *SIX1*/*SIX6* region has also been replicated in other Caucasian POAG cohorts \[[@B67-ijms-16-26135],[@B69-ijms-16-26135],[@B70-ijms-16-26135],[@B88-ijms-16-26135]\] but not in the African-Caribbean subjects \[[@B66-ijms-16-26135]\]. After the association of the *CDKN2B-AS1* region on chromosome 9p21, the second most consistent association with POAG has been observed in the *SIX1/SIX6* locus and so it would be interesting to know if this locus is associated with POAG in the Saudi or other Middle Eastern populations. However, currently there are no published reports of association of *SIX1*/*SIX6* locus with POAG in the middle-east population.

Recently, *11p11.2* (containing multiple genes), *ABCA1*, *ABO*, *AFAP1*, *ARHGEF12*, *FAR2*, *GGA3*, *GMDS*, *PKDREJ*, and *PMM2* were added to the newly discovered genes associated with POAG \[[@B46-ijms-16-26135],[@B47-ijms-16-26135],[@B50-ijms-16-26135],[@B51-ijms-16-26135],[@B52-ijms-16-26135]\]. These variants were significantly associated with glaucoma and the related functional visual field loss that could make them future study targets for glaucoma patients in the Middle East.

5. GWAS and Quantitative Endophenotype Traits {#sec5-ijms-16-26135}
=============================================

The genetic evaluation of quantitative endophenotype traits is often very useful in complex multifactorial diseases to understand the contribution of specific traits to the overall disease phenotype. A similar strategy has been successfully used in POAG to understand the contribution of proposed endophenotypes including IOP, VCDR, optic disc area and CCT to the overall disease process. GWASs have been performed to examine the genetic components of these endophenotypes in POAG and the normal population. van Koolwijk and colleagues performed a GWAS for IOP in POAG patients of European descent and identified SNPs rs11656696 and rs7555523, located in *GAS7* and *TMCO1*, respectively, suggesting a role for these two genes in IOP regulation \[[@B49-ijms-16-26135]\]. Other loci found to be associated with IOP so far include *FNDC3B*, *ABCA1*, *ABO*, *11p11.2*, *ARHGEF12* \[[@B50-ijms-16-26135],[@B52-ijms-16-26135]\]. Another three loci, *FAR2*, *GGA3*, and *PKDREJ*, did not reach a genome-wide significance level (*p* \< 10^−5^) \[[@B51-ijms-16-26135]\]. Three independent GWASs have evaluated the association of optic disc parameters (VCDR and optic disc area) in the normal general population. The loci associated included *ATOH7*, *CDC7/TGFBR3* and *SALL1*, *CARD10* for the optic disc area, and *CDKN2B*, *SIX1*, *SCYL1*/*LTBP3*, *CHEK2*, and *DCLK1*, in addition to *ATOH7*, for the VCDR \[[@B53-ijms-16-26135],[@B54-ijms-16-26135],[@B55-ijms-16-26135],[@B56-ijms-16-26135]\]. An exome sequencing also reported the *SIX6* locus to influence VCDR (*p* = 7.74 × 10^−7^) \[[@B57-ijms-16-26135]\]. A subsequent meta-analysis of the Rotterdam study with the Twin UK study \[[@B54-ijms-16-26135]\] demonstrated a strong association of *ATOH7*, *CDKN2B*, and *SIX1* in POAG with borderline association for *CDC7*/*TGFBR3* and *SALL4* (both *p* = 0.04). *CARD10* was not found to be associated with African-Caribbean POAG cases \[[@B66-ijms-16-26135]\], whereas *CHEK2* was reported to be associated with VCDR and HTG among the Japanese \[[@B67-ijms-16-26135]\] but not in Europeans \[[@B70-ijms-16-26135]\]. Moreover, multiple studies have provided strong evidence of association of *ATOH7* \[[@B66-ijms-16-26135],[@B67-ijms-16-26135],[@B68-ijms-16-26135],[@B69-ijms-16-26135]\] *CDKN2B*(-*AS1*) \[[@B66-ijms-16-26135],[@B67-ijms-16-26135],[@B69-ijms-16-26135],[@B70-ijms-16-26135],[@B74-ijms-16-26135]\] and *SIX1*/*SIX6* \[[@B69-ijms-16-26135],[@B70-ijms-16-26135]\] with POAG. CCT is an important risk factor for POAG in individuals with increased IOP, and over 26 loci have been reported \[[@B116-ijms-16-26135]\]. GWASs have identified several loci associated with CCT in the normal general population (Asian and European descent) and POAG cases (US Caucasians). These loci include *ZNF469*, *COL5A1*, *AKAP13*, *AVGR8*, and *COL8A2* \[[@B58-ijms-16-26135],[@B59-ijms-16-26135],[@B60-ijms-16-26135]\]. The *ZNF469* and *COL5A1* loci have been found to be associated with CCT in both the Caucasian and Asian cohorts \[[@B58-ijms-16-26135],[@B59-ijms-16-26135]\].

The possible role of these newly discovered loci associated with POAG and its endophenotypes in understanding the pathophysiology of POAG has been elegantly reviewed by Iglesias *et al.* elsewhere \[[@B117-ijms-16-26135]\]. The review integrates current knowledge in POAG from human and experimental data and dissects the contribution of the newly discovered genetic loci with the known molecular and biological processes, including extracellular matrix remodeling; TGF-β and tumor necrosis factor α (TNF-α) signaling; and the vascular tone pathway, that have been implicated in the pathogenesis of POAG.

6. Candidate Genes and POAG {#sec6-ijms-16-26135}
===========================

Recent reviews by Takamota and Araie \[[@B32-ijms-16-26135]\] and Janssen *et al.* \[[@B31-ijms-16-26135]\] presented a list of genes identified from numerous GWAS and association studies thus far. Taken together, the list of almost 50 genes may represent highly likely candidate genes that may be involved in POAG pathogenesis. Many studies have been performed to replicate the GWAS findings in the Asian, African-Caribbean and Caucasian/European populations using the candidate-gene approach \[[@B61-ijms-16-26135],[@B66-ijms-16-26135],[@B67-ijms-16-26135],[@B69-ijms-16-26135],[@B70-ijms-16-26135],[@B71-ijms-16-26135],[@B72-ijms-16-26135],[@B73-ijms-16-26135],[@B74-ijms-16-26135],[@B75-ijms-16-26135],[@B76-ijms-16-26135],[@B84-ijms-16-26135],[@B89-ijms-16-26135],[@B92-ijms-16-26135],[@B93-ijms-16-26135]\]. Also, many studies were performed to test the association of specific known genes/SNPs with POAG using the same approach in different populations including Middle Eastern \[[@B61-ijms-16-26135],[@B62-ijms-16-26135],[@B63-ijms-16-26135],[@B64-ijms-16-26135],[@B65-ijms-16-26135],[@B66-ijms-16-26135],[@B76-ijms-16-26135],[@B77-ijms-16-26135],[@B78-ijms-16-26135],[@B79-ijms-16-26135],[@B80-ijms-16-26135],[@B81-ijms-16-26135],[@B82-ijms-16-26135],[@B83-ijms-16-26135],[@B84-ijms-16-26135],[@B85-ijms-16-26135],[@B86-ijms-16-26135],[@B87-ijms-16-26135],[@B90-ijms-16-26135],[@B91-ijms-16-26135],[@B94-ijms-16-26135],[@B95-ijms-16-26135],[@B96-ijms-16-26135],[@B97-ijms-16-26135],[@B98-ijms-16-26135],[@B99-ijms-16-26135],[@B100-ijms-16-26135],[@B101-ijms-16-26135],[@B102-ijms-16-26135],[@B103-ijms-16-26135],[@B104-ijms-16-26135],[@B105-ijms-16-26135],[@B106-ijms-16-26135],[@B107-ijms-16-26135],[@B108-ijms-16-26135],[@B109-ijms-16-26135]\]. These SNP replication and genetic association studies in the Middle Eastern and other populations are also listed in [Table 1](#ijms-16-26135-t001){ref-type="table"}. Among these, consistent findings have been reported for *ATOH7* \[[@B66-ijms-16-26135],[@B67-ijms-16-26135],[@B68-ijms-16-26135],[@B69-ijms-16-26135]\], *CDKN2B*(-*AS1*) \[[@B66-ijms-16-26135],[@B67-ijms-16-26135],[@B69-ijms-16-26135],[@B70-ijms-16-26135],[@B74-ijms-16-26135]\], *GSTT1*/*GSTM1* \[[@B77-ijms-16-26135],[@B78-ijms-16-26135],[@B105-ijms-16-26135],[@B106-ijms-16-26135]\], *SIX1*/*SIX6* \[[@B69-ijms-16-26135],[@B70-ijms-16-26135]\] and *TMCO1* \[[@B92-ijms-16-26135],[@B93-ijms-16-26135]\] loci, indicating a potential role of these genes/loci in the pathogenesis of POAG. However, except for the glutathione-S transferase (GST) polymorphism, none of these loci have been either found to be associated with POAG (e.g., *CAV1*/*CAV2*, *CDC7*/*TGFBR3*, *FNDC3*) or the association has not been reported yet (e.g., *ATOH7*, *CDKN2B*(-*AS1*), *SIX1*/*SIX6*, *TMCO1*) in the Middle Eastern population. However, the positive findings of *GSTT1* and *GSTM1* genotypes in the Middle Eastern population may be very interesting, highlighting the role of anti-oxidants and/or oxidative stress-related pathways/mechanisms in the pathogenesis of POAG in this population. This view is strongly supported by recent meta-analysis studies that examined the association of GST polymorphisms and the risk of POAG \[[@B118-ijms-16-26135],[@B119-ijms-16-26135],[@B120-ijms-16-26135]\]. We have previously studied SNPs in two of the anti-oxidant genes, *CAT* (rs1001179) and *SOD2* (rs4880) \[[@B98-ijms-16-26135],[@B99-ijms-16-26135]\], in the Saudi POAG patients. However, the studies did not provide any direct association with POAG but indicated a trend towards an association with IOP and age of onset of POAG. In addition, some studies have demonstrated moderate evidence for association of SNPs in *TP53*, *NOS3*, *SEC14L2*/*TAP*, and *APOE* \[[@B96-ijms-16-26135],[@B97-ijms-16-26135],[@B103-ijms-16-26135],[@B107-ijms-16-26135]\]. However, these studies have been limited by sample size and would need further investigations in a large population-based cohort. The examination of causative genes such as *MYOC*, *OPTN* and *LOXL1* in Saudi POAG cases has also provided negative results \[[@B102-ijms-16-26135],[@B105-ijms-16-26135]\]. [Table 2](#ijms-16-26135-t002){ref-type="table"} list all genes associated with POAG and their possible role in POAG pathogenesis.

7. Final Remarks {#sec7-ijms-16-26135}
================

There is significant progress in understanding the genetic basis of POAG, largely due to the application of GWAS methodology in different populations. In recent years, GWASs have identified several loci associated with POAG including *CAV1/CAV2*, *TMCO1*, *CDKN2B-AS1*, *CDC7-TGFBR3*, *SIX1/SIX6*, *GAS7* and *ATOH7*.

The association between the *CDKN2B*(*-AS1*) locus on chromosome 9p21 and POAG has been extensively established across different populations and represents a major genetic risk factor for POAG. Studies involving the *SIX1/SIX6* and the *ATOH7* loci affecting the optic disc parameters and POAG itself have also been reproducible. Other loci seem to be more ethnicity-specific. *CAV1*/*CAV2* and *CDC7*-*TGFBR3* loci do not seem to contribute to POAG in the Middle East and the role of other newly discovered loci is yet to be established. Moreover, the *GSTT1*/*GSTM1* genotypes were found to be strongly associated with POAG in the Middle Eastern population and more studies may be needed to examine the role of oxidative stress and anti-oxidant pathways in this population.

Based on the current and new genes identified in glaucoma, it may be possible to develop an algorithm of SNP risk scores to assess the future risk of POAG in patients, which could be clinically useful. However, despite the tremendous progress, the genetic basis of POAG is still not completely understood and further investigations are needed to identify novel genes and pathways contributing to glaucoma that may help define disease-specific targets and facilitate the development of diagnostic and therapeutic strategies.

ijms-16-26135-t002_Table 2

###### 

Possible pathogenesis role of various genes associated with POAG.

  Gene          Gene Name                                                                                                                        Function                                                                              Role in Ophthalmic Diseases
  ------------- -------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *PLXDC2*      Plexin Domain Containing 2                                                                                                       May play a role in tumor angiogenesis                                                 Possible role through inhibition of angiogenesis and possible involvement in protecting against inflammation
  *TMTC2*       Transmembrane and Tetratricopeptide Repeat Containing 2                                                                          Protein binding calcium ion homeostasis                                               Unknown
  *ZP4*         Zona Pellucida Glycoprotein 4                                                                                                    Signal transducer activity                                                            Unknown
  *SRBD1*       S1 RNA Binding Domain 1                                                                                                          Nucleic acid binding, RNA binding, hydrolase activity, acting on ester bonds          Appears to contribute to glaucomatous optic neuropathy as a non--IOP-related genetic factor; exact mechanism is not known
  *ELOVL5*      ELOVL Fatty Acid Elongase 5                                                                                                      Catalytic activity                                                                    Appears to contribute to glaucomatous optic neuropathy as a non--IOP-related genetic factor; exact mechanism is not known
  *CAV1/CAV2*   Caveolin 1/Caveolin 2                                                                                                            Receptor binding, structural molecule activity                                        Dysfunction of cellular signaling and transport leading to the damage in tissues
  *CDKN2B-AS*   Cyclin-Dependent Kinase Inhibitor 2B                                                                                             Protein coding gene, inhibits CDK4                                                    Associated with systemic diseases inside and outside the eyes causing disruption in cell cycle
  *TMCO1*       Transmembrane And Coiled-Coil Domains 1                                                                                          Encoding transmembrane protein                                                        Association with cellular malfunction and oxidative stress
  *SIX1*        SIX Homeobox 1                                                                                                                   Regulation of cell proliferation, apoptosis and embryonic development.                Associated with developmental malformation of anterior angle, TM and CB
  *NCKAP5*      NCK-Associated Protein 5                                                                                                         Protein coding gene                                                                   Unknown
  *ABCA1*       ATP-Binding Cassette, Sub-Family A (ABC1), Member 1                                                                              Cholesterol carrying out of the cell                                                  Expressed highly in TM network, thought to be involved in raising IOP
  *AFAP1*       Actin Filament Associated Protein 1                                                                                              signaling pathways                                                                    Possible involvement in aqueous outflow and IOP
  *GMDS*        GDP-Mannose 4,6-Dehydratase                                                                                                      Catalytic activity                                                                    *GMDS* encodes a protein that is required for the first step in *de novo* synthesis of fucose. Fucose is required for diverse biological functions such as growth factor receptor signalling. Several studies have suggested the effects of growth factors on development of glaucoma
  *CDC7*        Cell Division Cycle 7                                                                                                            Phosphorylation                                                                       Impairment of cellular function in CB, TM and RGC
  *FNDC3B*      Fibronectin Type III Domain Containing 3B                                                                                        Poly(A) RNA binding                                                                   Associated with IOP through as yet unknown mechanism
  *GAS7*        Growth Arrest-Specific 7                                                                                                         Protein coding gene sequence-specific DNA binding transcription factor activity       Involved in developmental and functional impairment of RGC
  *ABO*         ABO Blood Group (Transferase A, Alpha 1-3-*N*-Acetylgalactosaminyltransferase; Transferase B, Alpha 1-3-Galactosyltransferase)   Basis of the ABO blood group system                                                   Thought to play a role in IOP elevation; Exact mechanism is not known
  *FAR2*        Fatty Acyl CoA Reductase 2                                                                                                       Catalytic activity                                                                    Unknown
  *GGA3*        Golgi-Associated, Gamma Adaptin Ear Containing, ARF Binding Protein 3                                                            Protein sorting and trafficking between the trans-Golgi network (TGN) and endosomes   Unknown
  *PKDREJ*      Polycystin (PKD) Family Receptor For Egg Jelly                                                                                   May have a central role in fertilization                                              Elevated IOP through undetermined mechanism
  *ARHGEF12*    Rho Guanine Nucleotide Exchange Factor (GEF) 12                                                                                  May play a role in the regulation of RhoA GTPase                                      Elevated IOP through undetermined mechanism
  *ATOH7*       Atonal Homolog 7                                                                                                                 Involved in the differentiation of retinal ganglion cells                             Involved in developmental problems of retinal vasculature
  *SALL1*       Spalt-Like Transcription Factor 1                                                                                                Organogenesis                                                                         SALL1 is involved in development of calcium homeostasis in the endoplasmic reticulum
  *RFTN1*       Raftlin, Lipid Raft Linker 1                                                                                                     Formation and/or maintenance of lipid rafts.                                          Related to vertical cup-to-disc ratio
  *CARD10*      Caspase Recruitment Domain Family, Member 10                                                                                     Protein binding, receptor signaling                                                   Developmental problems of neuronal tissues
  *COL5A1*      Collagen, Type V, Alpha 1                                                                                                        Fibril formation                                                                      Associated with malformation of connective tissues leading to problems in cornea and TM
  *ZNF469*      Zinc Finger Protein 469                                                                                                          Transcriptional regulation                                                            Thought to be involved in central corneal thickness
  *AKAP13*      A Kinase (PRKA) Anchor Protein 13                                                                                                Protein binding, cAMP-dependent protein kinase activity                               Involvement in corneal thickness and disruptions in signaling pathways in CB, TM and RGCs
  *COL8A2*      Collagen, Type VIII, Alpha 2                                                                                                     Protein binding, extracellular matrix structural constituent                          Associated with malformation of connective tissues leading to problems in cornea and TM
  *NTM*         Neurotrimin                                                                                                                      Protein binding                                                                       Unknown
  *APOE*        Apolipoprotein E                                                                                                                 Protein binding, receptor binding                                                     Role in oxidative stress and disrupted cellular homeostasis in CB, TM, LC and RGC
  *CHEK2*       Checkpoint Kinase 2                                                                                                              Protein kinase activity                                                               High expression is associated with problems in optic nerve and cup disk ratio
  *FBN1*        Fibrillin 1                                                                                                                      Extracellular matrix structural constituent                                           Mutations in FBN1 could cause backward bowing by compromising the mechanical properties of the iris
  *GSTT1*       Glutathione S-Transferase Theta 1                                                                                                Glutathione transferase activity                                                      Oxidative stress in all the POAG-involved tissues
  *NTF4*        Neurotrophin 4                                                                                                                   Protein binding, receptor binding                                                     Retinal ganglion cells survival and apoptosis
  *OPA1*        Optic Atrophy 1                                                                                                                  Protein binding                                                                       Involved in Oxidative stress in cornea, CB and TM
  *PAX6*        Paired Box 6                                                                                                                     Sequence-specific DNA binding RNA polymerase II transcription factor activity         Developmental impairment of neuro ophthalmic system
  *PLXDC2*      Plexin Domain Containing 2                                                                                                       Receptor binding                                                                      Developmental problems leading to fewer retinal ganglion cells
  *SIX6*        SIX Homeobox 6                                                                                                                   DNA binding, protein binding                                                          Associated with developmental malformation of anterior angle, TM and CB
  *TLR4*        Toll-Like Receptor 4                                                                                                             Receptor binding                                                                      Involved in Oxidative stress and decreased cellular viability
  *TMTC2*       Transmembrane And Tetratricopeptide Repeat Containing 2                                                                          Identical protein binding                                                             TMTC2 is implicated in calcium homeostasis in the endoplasmic reticulum
  *TNF*α        Tumor Necrosis Factor                                                                                                            Protease binding, cytokine activity                                                   May be activated in reaction to POAG-related indices (increased IOP, oxidative stress and increase in disregulation of cellular homeostasis
  *VAV2*        Vav 2 Guanine Nucleotide Exchange Factor                                                                                         Epidermal growth factor receptor binding                                              Unknown
  *LOXL1*       Lysyl Oxidase-Like 1                                                                                                             Copper ion binding                                                                    Through the loss of elastin formation and resulting friction between the iris and the anterior lens capsule
  *ZNF469*      Zinc Finger Protein 469                                                                                                          DNA binding                                                                           Associated with developmental malformation of connective tissues leading to problems in cornea and TM
  *Zp4*         Zona Pellucida Glycoprotein 4                                                                                                    Signal transducer activity                                                            Unknown
  *TP53*        Tumor Protein P53                                                                                                                Core promoter sequence-specific DNA binding                                           Unknown
  *NOS3*        Nitric Oxide Synthase 3 (Endothelial Cell)                                                                                       Receptor binding                                                                      Dysregulation of the vascular tone particularly through interaction with endothelial nitric oxide synthase and production of nitric oxide (NO) in the vascular endothelia. This may lead to decreased AH outflow and increased IOP
  *CAT*         Catalase                                                                                                                         Catalytic activity                                                                    Detoxification of reactive oxygen species---linked to POAG through oxidative stress
  *SOD2*        Superoxide Dismutase 2, Mitochondrial                                                                                            Oxygen binding, DNA binding                                                           Possible role through oxidative stress mechanism
  *OPTN*        Optineurin                                                                                                                       Protein binding                                                                       Through oxidative stress/the mitochondrial caspase-dependent cell death
  *TTPA*        Tocopherol (Alpha) Transfer Protein                                                                                              Transporter activity                                                                  Linked to vitamin C loss and that in turn is linked to POAG development through yet undiscovered mechanism
  *RBP1*        Retinol Binding Protein 1, Cellular                                                                                              Transporter activity, retinoid binding                                                Through retinol and oxidative stress mechanism
  *MTHFR*       Methylenetetrahydrofolate Reductase (NAD(P)H)                                                                                    Methylenetetrahydrofolate reductase (NAD(P)H) activity                                Linked through homocysteine level, link to POAG is not established
  *GPX4*        Glutathione Peroxidase 4                                                                                                         Glutathione peroxidase activity                                                       Effect on decreased level of vitamins E and C. Lower level of vitamin C is linked to glaucoma through unknown mechanism.
  *SEC14L2*     SEC14-Like 2 (*S. Cerevisiae*)                                                                                                   Phospholipid binding                                                                  Effect on decreased level of vitamin C. Lower level of vitamin C is linked to glaucoma through unknown mechanism
  *SLC23A1*     Solute Carrier Family 23 (Ascorbic Acid Transporter), Member 1                                                                   Nucleobase transmembrane transporter activity                                         Effect on decreased level of vitamin C. Lower level of vitamin C is linked to glaucoma through unknown mechanism
  *PMM2*        Phosphomannomutase 2                                                                                                             Catalytic activity                                                                    Expressed highly in TM network, thought to be involved in raising IOP
  *SLC23A2*     Solute Carrier Family 23 (Ascorbic Acid Transporter), Member 2                                                                   Nucleobase transmembrane transporter activity                                         May be through lowering the plasma level of vitamin C. Low level of vitamin C was found in POAG patients carrying mutation in this gene. Exact link between low vitamin C level and POAG is not determined

Since the advent of GWAS studies, more and more genes and SNPs have been discovered in association of POAG. However, the usefulness (in term of clinical application and developing therapeutic modalities) of those discoveries is still limited. It will take multiple genotype-phenotype studies in various centers and multiethnic groups before establishing the applicability of those SNPs and/or genes to POAG or POAG clinical indices. As for the development of new therapeutic agents, the process will be lengthy and may take several years before effective therapeutic modalities for POAG are available. The whole process from discovering new genetic markers (SNPs) or genes to developing new therapeutic agents may take several steps and many years. Those steps are: (i) Discover those genes and/or SNPs associated with POAG, which is underway thanks to new emerging technologies in molecular genetics such as exome sequencing and GWAS technologies. This may take up to 10 years to complete; (ii) Establish the association of various SNPs and genes with POAG in various ethnicities, larger cohorts, and in multiple centers. This is important as initial discovery studies are conducted on specific ethnicities and in smaller cohorts; (iii) Conduct functional studies in order to understand how those genes and/or SNPs contribute to POAG pathogenesis; (iv) Develop therapeutic agents based on our understanding of the function of the genes associated with POAG. This step is the longest and expected to take at least 10--15 years. This should not hold us back or make us think less of genetic studies as those may prove to be the only way to improve our current understanding of the etiology of glaucoma and facilitate the development of diagnostic and therapeutic strategies.
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